Big Food vs. Big Pharma: Companies Bet on Snacking Just as Weight Loss Drugs Boom
October 2, 2023
Major food companies are doubling down on snacking as consumer habits shift, but the rise of weight loss drugs like Wegovy and Ozempic poses a potential threat to their growth. These drugs, known as GLP-1 agonists, suppress appetites and can lead to aversions to sugary and fatty foods, which are core offerings of many big snack brands. While the pharmaceuticals’ success could lead to slower sales for snack producers, their high cost and other factors suggest that the immediate impact may be limited, giving food companies time to adapt.
Recent News
NHTSA Investigates Tesla Autopilot Again After Recent Software Update
Tesla Autopilot is once again the subject of an NHTSA investigation.
Home Depot Holds Halfway to Halloween Sale: Skelly’s Back
It’s halfway to spooky season, and Home Depot is celebrating.
Kaiser Discloses Health Insurance Data Breach
Health insurance company Kaiser is notifying millions of its current and former members about a data breach. The breach occurred when Kaiser shared patients’ information with third-party advertisers like Google, Microsoft, and X (formerly Twitter).
Satirical Site The Onion Acquired by Global Tetrahedron
The satirical news website, The Onion, has been sold by G/O Media to a group of digital media veterans.